• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Sun, 12.04.26

Search results


April 2026
Erez Magiel MD, Melanie Shanie Roitman MD, Barak Pflantzer MD, Ofir Kotek MD, Daniela Noa Zohar MD, Arnon Afek MD, Nicola Maggio MD PhD, Roni Loebenstein MD

Background: Patient satisfaction is a key indicator of healthcare quality, influencing treatment adherence, clinical outcomes, and hospital reputation. The relationship between length of hospital stay (LOS) and patient satisfaction in neurological inpatients remains understudied, particularly regarding sex differences and neurological diagnosis types.

Objectives: To understand how LOS influences satisfaction and patient experience. To evaluate care strategies and improve communication in neurological settings.

Methods: We conducted a retrospective observational study of 181 patients admitted to the neurology department at Sheba Medical Center between January 2023 and January 2025. Patient satisfaction was assessed using a standardized survey covering overall experience, communication with medical staff, and the discharge process. We used partial correlation analyses and multivariate ANOVA to explore associations of LOS, sex, diagnosis, and satisfaction.

Results: A significant negative correlation was found between LOS and patient satisfaction (r = -0.19, P = 0.012), as well as with perceptions of competency (r = -0.22, P = 0.004), physician communication, and involvement in treatment decisions. Females reported lower satisfaction than males, particularly regarding hospitalization conditions, the discharge process, and staff communication. Diagnosis-specific differences also emerged, with females diagnosed with headache consistently reporting the lowest satisfaction ratings.

Conclusions: Longer hospital stays were associated with lower patient satisfaction. Female sex and diagnosis of headaches influenced patient satisfaction the most. These findings highlight the need for improved communication and enhanced discharge planning to optimize patient satisfaction in neurological settings. Addressing these factors may contribute to more patient-centered care and better overall experiences for hospitalized neurological patients.

November 2023
Erez Magiel MD, Christopher J. Klein MD, Shahar Shelly MD

In the acute settings of generalized myasthenia gravis (MG) treatment options include plasma exchange (PLEX), intravenous immunoglobulin (IVIG), and pyridostigmines. A thymoma is associated with the disease in up to 20% of cases [1,2].

In cases where a thymoma is detected, surgical treatment to remove the tumor is recommended in certain age groups. At present, there are no clear guidelines regarding the optimal time to perform thymectomy after diagnosis of acute crisis or from the last treatment to thymectomy. Treatment is at the clinician's discretion.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel